TTR and neuropathy: Indeed, while the first therapies discovered aimed to stabilize the tetramer of TTR (even if new amyloid fibrils might accumulate in tissues of patients), the most recent drugs for the treatment of ATTRv are based on RNA-interference mechanisms, and they almost completely stop the production of TTR as a result of complete stabilization of the disease and mild recovery from symptoms of neuropathy (4–6).